These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 358802)

  • 1. Daunomycin: an anthracycline antibiotic effective in acute leukemia.
    Von Hoff DD; Rozencweig M; Slavik M
    Adv Pharmacol Chemother; 1978; 15():1-50. PubMed ID: 358802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rubidomycin-daunomycin, a new antibiotic with antineoplastic effect].
    Dano K; Nissen NI
    Nord Med; 1968 Oct; 80(44):1469-74. PubMed ID: 5247179
    [No Abstract]   [Full Text] [Related]  

  • 3. Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance.
    Kessel D; Wilberding C; Karanes C; Ratanatharathorn V
    Cancer Lett; 1984 Oct; 24(3):305-9. PubMed ID: 6594191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
    Busche R; Tümmler B; Riordan JR; Cano-Gauci DF
    Mol Pharmacol; 1989 Apr; 35(4):414-21. PubMed ID: 2565017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial and antineoplastic antibiotics].
    Gol'dberg LE
    Sov Med; 1977 Oct; (10):115-23. PubMed ID: 201038
    [No Abstract]   [Full Text] [Related]  

  • 6. Biophysical chemistry of the daunomycin-DNA interaction.
    Chaires JB
    Biophys Chem; 1990 Apr; 35(2-3):191-202. PubMed ID: 2204442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
    Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
    Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attemp at treatment of acute leukemia and Hodgkin's disease by rubidomycin or daunomycin alone or combined].
    Mathe G; Amiel JL; Hayat M; Schwarzenberg L; Schenider M; Cattan A; Schlumberger JR; Ceoara B
    Sem Hop; 1967 Jul; 43(32):2108-14. PubMed ID: 4328374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rubidomycin-daunomycin therapy in acute myeloblastic leukemia].
    Dano K; Nissen NI; Pedersen-Bjergaard J; Thiede T
    Nord Med; 1968 Oct; 80(44):1475-82. PubMed ID: 5247180
    [No Abstract]   [Full Text] [Related]  

  • 10. Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.
    Seymour LW; Duncan R; Kopecková P; Kopecek J
    Cancer Treat Rev; 1987 Dec; 14(3-4):319-27. PubMed ID: 3326668
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on toxicity and clinical trials with daunomycin.
    Serpick AA; Henderson ES
    Pathol Biol; 1967 Oct; 15(19):909-12. PubMed ID: 4967536
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequence selective binding of ditrisarubicin B to DNA: comparison with daunomycin.
    Fox KR; Kunimoto S
    FEBS Lett; 1989 Jul; 250(2):323-7. PubMed ID: 2753137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracyclines--modern tumour-inhibiting agents.
    Strauss DG
    Folia Microbiol (Praha); 1978; 23(2):152-61. PubMed ID: 348587
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daunorubicin in patients with relapsed and refractory acute nonlymphoblastic leukemia previously treated with anthracycline.
    Velu T; Debusscher L; Stryckmans P
    Am J Hematol; 1988 Mar; 27(3):224-5. PubMed ID: 3162347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells.
    Varga JM; Asato N; Lande S; Lerner AB
    Nature; 1977 May; 267(5606):56-8. PubMed ID: 193043
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
    Woodman RJ
    Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
    [No Abstract]   [Full Text] [Related]  

  • 19. Adriamycin and related anthracycline antibiotics.
    Brown JR
    Prog Med Chem; 1978; 15():125-64. PubMed ID: 400611
    [No Abstract]   [Full Text] [Related]  

  • 20. A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity.
    Andrivon W; Callais F; Nafziger J; Monneret C; Guillosson JJ
    Mutat Res; 1995 Oct; 344(3-4):135-40. PubMed ID: 7491131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.